Recombinant Human FEN1
Cat.No. : | FEN1-28168TH |
Product Overview : | Recombinant full length Human FEN1; amino acids 1-380, MWt 42.5kDa. |
- Specification
- Gene Information
- Related Products
Description : | The protein encoded by this gene removes 5 overhanging flaps in DNA repair and processes the 5 ends of Okazaki fragments in lagging strand DNA synthesis. Direct physical interaction between this protein and AP endonuclease 1 during long-patch base excision repair provides coordinated loading of the proteins onto the substrate, thus passing the substrate from one enzyme to another. The protein is a member of the XPG/RAD2 endonuclease family and is one of ten proteins essential for cell-free DNA replication. DNA secondary structure can inhibit flap processing at certain trinucleotide repeats in a length-dependent manner by concealing the 5 end of the flap that is necessary for both binding and cleavage by the protein encoded by this gene. Therefore, secondary structure can deter the protective function of this protein, leading to site-specific trinucleotide expansions. |
Source : | E. coli |
Form : | Liquid |
Purity : | >90% by SDS-PAGE |
Storage buffer : | Preservative: NoneConstituents: 10% Glycerol, 20mM Tris HCl, 1mM DTT, pH 8.0 |
Storage : | Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. |
Sequences of amino acids : | MGIQGLAKLI ADVAPSAIRE NDIKSYFGRK VAIDASMSIY QFLIAVRQGG DVLQNEEGET TSHLMGMFYR TIRMMENGIK PVYVFDGKPP QLKSGELAKR SERRAEAEKQ LQQAQAAGAE QEVEKFTKRL VKVTKQHNDE CKHLLSLMGI PYLDAPSEAE ASCAALVKAG KVYAAATEDM DCLTFGSPVL MRHLTASEAK KLPIQEFHLS RILQELGLNQ EQFVDLCILL GSDYCESIRG IGPKRAVDLI QKHKSIEEIV RRLDPNKYPV PENWLHKEAH QLFLEPEVLD PESVELKWSE PNEEELIKFM CGEKQFSEER IRSGVKRLSK SRQGSTQGRL DDFFKVTGSL SSAKRKEPEPKGSTKKKAKT GAAGKFKRGK |
Sequence Similarities : | Belongs to the XPG/RAD2 endonuclease family. FEN1 subfamily. |
Gene Name : | FEN1 flap structure-specific endonuclease 1 [ Homo sapiens ] |
Official Symbol : | FEN1 |
Synonyms : | FEN1; flap structure-specific endonuclease 1; RAD2; flap endonuclease 1; DNase IV; FEN 1; maturation factor 1; MF1; |
Gene ID : | 2237 |
mRNA Refseq : | NM_004111 |
Protein Refseq : | NP_004102 |
MIM : | 600393 |
Uniprot ID : | P39748 |
Chromosome Location : | 11q12 |
Pathway : | Base Excision Repair, organism-specific biosystem; Base excision repair, organism-specific biosystem; Base excision repair, conserved biosystem; Cell Cycle, Mitotic, organism-specific biosystem; Chromosome Maintenance, organism-specific biosystem; |
Function : | 5-3 exonuclease activity; 5-flap endonuclease activity; 5-flap endonuclease activity; DNA binding; damaged DNA binding; |
Products Types
◆ Recombinant Protein | ||
FEN1-013H | Recombinant Human FEN1 Protein, His-tagged | +Inquiry |
Fen1-2986M | Recombinant Mouse Fen1 Protein, Myc/DDK-tagged | +Inquiry |
FEN1-1971R | Recombinant Rat FEN1 Protein, His (Fc)-Avi-tagged | +Inquiry |
FEN1-1235H | Recombinant Human FEN1 Protein (G2-K380), Tag Free | +Inquiry |
FEN1-1477H | Recombinant Human FEN1 Protein, His-tagged | +Inquiry |
◆ Lysates | ||
FEN1-6264HCL | Recombinant Human FEN1 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionMutations in the FEN1 protein can be detected and analyzed by methods such as whole-genome sequencing or target region sequencing to understand the impact of mutations on protein structure and function.
The FEN1 protein can be used as a biomarker in medical therapy to help monitor disease progression and treatment efficacy. In addition, therapeutics targeting the FEN1 protein, such as inhibiting its activity or regulating its expression, are also being investigated.
Abnormal levels of the FEN1 protein may suggest a genetic disorder such as cancer or neurofibroma, but it may also be associated with other diseases.
Studying the regulatory mechanism of FEN1 protein requires a combination of various experimental methods and techniques, such as gene knockout, transcriptome analysis, and protein-protein interactions.
Deficiency or aberrant expression of FEN1 protein may be associated with some cancers and genetic diseases, such as lung cancer, bowel cancer, neurofibromas, etc.
The types of mutations in the FEN1 protein include point mutations, insertions/deletions, duplications, etc., which may cause structural and functional abnormalities of the protein.
Customer Reviews (3)
Write a reviewFEN1 has strong stability.
It shows excellent stability in production.
FEN1 is easy to operate.
Ask a Question for All FEN1 Products
Required fields are marked with *
My Review for All FEN1 Products
Required fields are marked with *
Inquiry Basket